Iisrael - heebrea - Ministry of Health

omrix biopharmaceuticals ltd, israel - human immunoglobulin - תמיסה להזרקה - human immunoglobulin 5 g / 100 ml - specific immunoglobulins - passive immunization for the prevention of hepatitis b virus re-infection after liver transplantation.

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - adalimumab 40 mg / 0.8 ml - solution for injection - pfs - adalimumab - * rheumatoid arthritis: humira in combination with methotrexate is indicated for: - the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. - the treatment of severe active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. humira has been shown to reduce the rate of progression of joint damage as measured by x-ray adn to impove physical function when given in combination with methotrexate. * crohn's disease : humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active crohn's disease who have had an inadequate response to conventional therapy.humira is indicated for reducing signs and symptoms and inducing clinical r

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - adalimumab 40 mg / 0.8 ml - solution for injection - vial - adalimumab - * rheumatoid arthritis: humira in combination with methotrexate is indicated for: - the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. - the treatment of severe active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. humira has been shown to reduce the rate of progression of joint damage as measured by x-ray adn to impove physical function when given in combination with methotrexate. * crohn's disease : humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active crohn's disease who have had an inadequate response to conventional therapy.humira is indicated for reducing signs and symptoms and inducing clinical r

Iisrael - heebrea - Ministry of Health

omrix biopharmaceutic - רופא - אביזר מודולרי לשימוש עם פיברין סילנט+אביזרים

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 10 mg - venetoclax

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 100 mg - venetoclax

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - sevoflurane - נוזל לשאיפה - sevoflurane 100 % - sevoflurane

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - sevoflurane - נוזל לשאיפה - sevoflurane 100 % - sevoflurane

Iisrael - heebrea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות רכות - paricalcitol 1 mcg - paricalcitol